The physician and his practice also had to sign into a “multi-year integrity agreement” that includes specific training and reporting requirements.

It was important for researchers to confirm these stents didn't increase a patient's long-term risk of adverse events.

The FDA’s decision was based largely on clinical data from the first 21 patients to receive the device.

Experts think these new findings could ramp up the development of optimal revascularization strategies.

The system preserves hearts that can’t be procured or transplanted right away due to a limited availability of storage space.

Inpatient care for PCI is trending in the right direction, researchers explained, but there is still room for improvement. 

Researchers aimed to gain a better understanding of a controversial topic. 

An interventional cardiologist at Toronto General Hospital performed the procedures. 

The team behind the trial thinks this technology could help cut down on unnecessary invasive procedures. 

Researchers tracked data from more than 3,600 patients who underwent either carotid endarterectomy or carotid artery stenting.

Should CABG and PCI patients be concerned about potential long-term cognitive issues? The current evidence is unclear.